Profilo
Wendy S.
Arnold worked as the Director of Human Resources at Avila Therapeutics, Inc. from 2011 to 2014.
She then worked as the Head of Human Resources at Moderna, Inc. from 2014 to 2017.
In 2018, she became the Senior Vice President of Human Resources at Kaleido Biosciences, Inc. until 2020.
From 2020 to 2023, she served as the Chief People Officer at Frequency Therapeutics, Inc. Ms. Arnold received an undergraduate degree from Colorado State University.
Precedenti posizioni note di Wendy Arnold
| Società | Posizione | Fine |
|---|---|---|
| KORRO BIO, INC. | Ufficiale delle Risorse Umane | 31/03/2023 |
| KALEIDO BIOSCIENCES, INC. | Ufficiale delle Risorse Umane | 31/01/2020 |
| MODERNA, INC. | Ufficiale delle Risorse Umane | 01/12/2017 |
Avila Therapeutics, Inc.
Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops covalent drugs | Ufficiale delle Risorse Umane | 01/01/2014 |
Formazione di Wendy Arnold
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Colorado State University
Colorado State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avila Therapeutics, Inc.
Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops covalent drugs | Health Technology |
Kaleido Biosciences, Inc.
Kaleido Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company which develops therapeutic products to systematically shape the micro biome | Health Technology |
Frequency Therapeutics, Inc.
Frequency Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company which develops small molecule drugs to repair damage caused by degenerative diseases | Health Technology |
Moderna, Inc.
Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
















